{"name": "Clovis Oncology",
 "permalink": "clovis-oncology",
 "crunchbase_url": "http://www.crunchbase.com/company/clovis-oncology",
 "homepage_url": "http://clovisoncology.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "clovisoncology",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Oncology Compound Licencing Company",
 "created_at": "Wed Jun 17 19:11:54 UTC 2009",
 "updated_at": "Sun Mar 31 09:31:36 UTC 2013",
 "overview": "\u003Cp\u003EClovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0017/8043/178043v1-max-150x150.png"],
     [[250,
       65],
      "assets/images/resized/0017/8043/178043v1-max-250x250.png"],
     [[262,
       69],
      "assets/images/resized/0017/8043/178043v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [{"name": "Clovis Oncology",
    "permalink": "clovis-oncology",
    "image": null}],
 "relationships":
  [{"is_past": false,
    "title": "Founder",
    "person":
     {"first_name": "Andrew",
      "last_name": "Allen",
      "permalink": "andrew-allen",
      "image": null}},
   {"is_past": false,
    "title": "co-founder, CEO \u0026 President ",
    "person":
     {"first_name": "Patrick",
      "last_name": "Mahaffy",
      "permalink": "patrick-mahaffy",
      "image":
       {"available_sizes":
         [[[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-150x150.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-250x250.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Brian",
      "last_name": "Atwood",
      "permalink": "brian-atwood",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0026/4120/264120v1-max-150x150.jpg"],
          [[187,
            250],
           "assets/images/resized/0026/4120/264120v1-max-250x250.jpg"],
          [[225,
            300],
           "assets/images/resized/0026/4120/264120v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$145M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/clovis-oncology-inc-series-a-145m/",
    "source_description": "Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development",
    "raised_amount": 145000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aberdare Ventures",
         "permalink": "aberdare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0005/3038/53038v1-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0005/3038/53038v1-max-250x250.jpg"],
             [[300,
               57],
              "assets/images/resized/0005/3038/53038v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ProQuest Investments",
         "permalink": "proquest-investments",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.masshightech.com/stories/2012/01/16/daily36-Avila-spears-4M-in-milestone-payment-from-Clovis--.html",
      "source_description": "Avila spears $4M in milestone payment from Clovis ",
      "raised_amount": 4000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2012,
      "funded_month": 1,
      "funded_day": 20,
      "company":
       {"name": "Avila Therapeutics",
        "permalink": "avila-therapeutics",
        "image":
         {"available_sizes":
           [[[110,
              93],
             "assets/images/resized/0014/3663/143663v1-max-150x150.jpg"],
            [[110,
              93],
             "assets/images/resized/0014/3663/143663v1-max-250x250.jpg"],
            [[110,
              93],
             "assets/images/resized/0014/3663/143663v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "2525 28th Street",
    "address2": "Suite 100",
    "zip_code": "80301",
    "city": "Boulder",
    "state_code": "CO",
    "country_code": "USA",
    "latitude": 40.026,
    "longitude": -105.259041}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2011,
   "pub_month": 11,
   "pub_day": 16,
   "stock_symbol": "NASDAQ:CLVS"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}